The 2024 Microbiome Movement-Drug Development Summit Start-Up Showcase will offer the opportunity for emerging microbiome therapeutic start-up organisations to showcase their innovative research, technology, expert team and commercial strategy in front of a panel of world class microbiome VCs and investors and a room full of the industry’s most prominent global biotech and pharma.

With prizes at stake, the judging panel will decide who to award as winner of the Microbiome Movement Start-up Showcase 2024.

Across institutional and corporate VCs, those involved as judges will have oversight over the full application and selection process to see the full scope of companies applying.

By providing a hot spot for organisations with brand new innovative technologies targeting a variety of indications,
start-ups can profile their work, investors can meet emerging companies and large pharma can uncover promising R&D, paving the way for novel therapeutic strategies targeting host:microbiome interactions.